title: [Efficiency and safety of lipid-lowering therapy for chronic kidney disease].
abstract: The paper considers the problem of lipid-lowering therapy for chronic kidney disease, by using different groups of drugs, the expediency, efficiency, and safety of the therapy at different disease stages, including end-stage renal failure, and replacement treatments.
authors.forename: I B
authors.initials: IB
authors.lastname: Kolina
authors.forename: E V
authors.initials: EV
authors.lastname: Stavrovskaia
mesh_terms: D002318:Cardiovascular Diseases / Q000378:metabolism / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D000960:Hypolipidemic Agents